National Medical Insurance Administration seeks public opinions on the "Guidelines for Comprehensive Evaluation of Real-World Medical Insurance Value of Drugs"

On January 14th, the National Healthcare Security Administration announced the release of a series of guidelines for the comprehensive evaluation of the real-world medical insurance value of drugs. In order to accelerate the establishment of a national unified drug real-world medical insurance comprehensive value evaluation system, in accordance with the requirements of the Notice on the Pilot Work of Real-World Medical Insurance Comprehensive Value Evaluation, the National Healthcare Security Administration's Medical Price and Tender Procurement Guidance Center has drafted the "Guidelines for the Comprehensive Evaluation of Drug Real-World Medical Insurance Value." Public opinions are now being solicited from the society.